Japan Clinical Decision Support Systems (CDSS) Market (2025-2030)

RESEARCH METHODOLOGY

The study involved five major activities to estimate the current size of the clinical decision support systems (CDSS) market. Exhaustive secondary research was conducted to collect information on the market and its subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the total market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

This research study relied extensively on secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings. Secondary research was used to identify and collect valuable information for this study. It was also used to obtain important information about the key players, market classification and segmentation according to industry trends down to the bottom-most level, and key market & technology developments. A database of the key industry leaders was also prepared using secondary research.

Some of the key secondary sources referred to for this study include:

• Healthcare Information and Management Systems Society (HIMSS)
• American Medical Informatics Association (AMIA)
• Agency for Healthcare Research and Quality (AHRQ)
• American Association of Healthcare Administrative Management (AAHAM)
• Organization for Economic Co-operation and Development (OECD)
• World Health Organization (WHO)
• Centers for Disease Control and Prevention (CDC)
• Institute for Health Technology Transformation (iHT2)
• American Medical Group Association (AMGA)
• International Association of Health Policy (IAHP)
• Institute of Population and Public Health (IPPH)
• Public Health Agency of Canada
• European Federation for Medical Informatics (EFMI)
• Australian Healthcare and Hospitals Association
• Investor Presentations, SEC Filings, and Company Annual Reports
• White Papers, Journals/Magazines, and News Articles
• Paid Databases, such as Factiva, D&B Hoovers, and Bloomberg Business

Primary Research

Extensive primary research was conducted after acquiring basic knowledge of the global CDSS market through secondary research. Several primary interviews were conducted with market experts from both the demand side (hospital directors, hospital vice presidents, department heads, and critical care specialists) and the supply side (C- and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. This primary data was collected through questionnaires, emails, online surveys, personal interviews, and telephone interviews. In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources are mainly industry experts from core and related industries, solution providers, technology vendors, system integrators, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and assess prospects. Primary research was conducted to identify segmentation types, industry trends, key players, and key market dynamics such as drivers, restraints, opportunities, challenges, and strategies adopted by key players.

Note 1: C-level primaries include CEOs, CFOs, and CoOs.
Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = <USD 50 million.

To know about the assumptions considered for the study, download the pdf brochure